Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 19
2003 49
2004 94
2005 116
2006 142
2007 109
2008 114
2009 141
2010 141
2011 125
2012 172
2013 187
2014 191
2015 184
2016 162
2017 181
2018 159
2019 198
2020 200
2021 182
2022 193
2023 174
2024 174
2025 183
2026 107

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,181 results

Results by year

Filters applied: . Clear all
Page 1
Tadalafil.
Curran M, Keating G. Curran M, et al. Drugs. 2003;63(20):2203-12; discussion 2213-4. doi: 10.2165/00003495-200363200-00004. Drugs. 2003. PMID: 14498756 Review.
Improvement in scores on other domains of the IIEF and the percentage of positive responses to a Global Assessment Question measuring erection improvement were also significantly greater with on-demand tadalafil than placebo. black triangle The adverse events associated wi …
Improvement in scores on other domains of the IIEF and the percentage of positive responses to a Global Assessment Question measuring erecti …
Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.
Gong B, Ma M, Xie W, Yang X, Huang Y, Sun T, Luo Y, Huang J. Gong B, et al. Int Urol Nephrol. 2017 Oct;49(10):1731-1740. doi: 10.1007/s11255-017-1644-5. Epub 2017 Jul 24. Int Urol Nephrol. 2017. PMID: 28741090 Free PMC article.
However, compared with sildenafil, tadalafil significantly improved psychological outcomes. Furthermore, the patients and their partners preferred tadalafil over sildenafil, and no significant difference was found in the adherence and persistence rates between ta …
However, compared with sildenafil, tadalafil significantly improved psychological outcomes. Furthermore, the patients and their partn …
Tadalafil for the treatment of benign prostatic hyperplasia.
Mónica FZ, De Nucci G. Mónica FZ, et al. Expert Opin Pharmacother. 2019 Jun;20(8):929-937. doi: 10.1080/14656566.2019.1589452. Epub 2019 Mar 22. Expert Opin Pharmacother. 2019. PMID: 30901259 Review.
Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It includes details of the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) - PDE5 pathway in the LUT organs (bladder and p …
Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It …
Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction.
Cui H, Liu B, Song Z, Fang J, Deng Y, Zhang S, Wang H, Wang Z. Cui H, et al. Andrologia. 2015 Feb;47(1):20-4. doi: 10.1111/and.12216. Epub 2014 Jan 6. Andrologia. 2015. PMID: 24387078 Clinical Trial.
We enrolled 180 patients with ED 1 : 1 to tadalafil 5 mg once daily or once-a-day tadalafil 5 mg combined with sildenafil 50 mg as needed. ...Total IIEF-5 scores of patients with severe ED in combined medication group were significantly higher than in tadalafil …
We enrolled 180 patients with ED 1 : 1 to tadalafil 5 mg once daily or once-a-day tadalafil 5 mg combined with sildenafil 50 m …
Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia.
Jehle DVK, Sunesra R, Uddin H, Paul KK, Joglar AA, Michler OD, Blackwell TA, Gaalema D, Hayek S, Jneid H. Jehle DVK, et al. Am J Med. 2025 Mar;138(3):441-448.e3. doi: 10.1016/j.amjmed.2024.10.039. Epub 2024 Nov 10. Am J Med. 2025. PMID: 39532245
Men at least 40 years of age prescribed tadalafil or sildenafil after an erectile dysfunction diagnosis, or tadalafil after lower urinary tract symptom diagnoses, from 2004 to 2021 were included. ...CONCLUSIONS: In conclusion, tadalafil and sildenafil use in …
Men at least 40 years of age prescribed tadalafil or sildenafil after an erectile dysfunction diagnosis, or tadalafil after lo …
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.
Sebastianelli A, Spatafora P, Morselli S, Vignozzi L, Serni S, McVary KT, Kaplan S, Gravas S, Chapple C, Gacci M. Sebastianelli A, et al. Curr Urol Rep. 2020 Oct 27;21(12):56. doi: 10.1007/s11934-020-01009-7. Curr Urol Rep. 2020. PMID: 33108544 Free PMC article.
After discontinuation of tamsulosin or tadalafil in patients previously treated with their combination, the improvement of LUTS retains significance compared with baseline. Tadalafil 5 mg should be considered a primary treatment option for patients with LUTS/BPH and …
After discontinuation of tamsulosin or tadalafil in patients previously treated with their combination, the improvement of LUTS retai …
Potential beneficial impacts of tadalafil on cardiovascular diseases.
Lan TY, Chiang CH, Chen JW, Chang TT. Lan TY, et al. J Chin Med Assoc. 2025 Apr 1;88(4):267-272. doi: 10.1097/JCMA.0000000000001205. Epub 2025 Jan 10. J Chin Med Assoc. 2025. PMID: 39789694 Free PMC article. Review.
Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor commonly used for the treatment of erectile dysfunction and benign prostatic hyperplasia. ...Although tadalafil shows potential efficacy in treating cardiovascular disease, further experimental studi …
Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor commonly used for the treatment of erectile dysfunction and benign …
Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives.
Greco EA, Antinozzi C, Di Luigi L, Aversa A, Sgrò P. Greco EA, et al. Int J Mol Sci. 2022 Apr 11;23(8):4191. doi: 10.3390/ijms23084191. Int J Mol Sci. 2022. PMID: 35457011 Free PMC article. Review.
Tadalafil is a selective phosphodiesterase type-5 (PDE5) inhibitor that is approved for the treatment of men with erectile dysfunction (ED) and/or benign prostate hyperplasia (BPH) -associated symptoms. ...In this review, we summarize basic research and translational resul …
Tadalafil is a selective phosphodiesterase type-5 (PDE5) inhibitor that is approved for the treatment of men with erectile dysfunctio …
Tadalafil: in pulmonary arterial hypertension.
Croxtall JD, Lyseng-Williamson KA. Croxtall JD, et al. Drugs. 2010 Mar 5;70(4):479-88. doi: 10.2165/11204580-000000000-00000. Drugs. 2010. PMID: 20205489 Review.
Both the time to the first occurrence of clinical worsening and the incidence of clinical worsening were significantly reduced in recipients of tadalafil 40 mg once daily compared with recipients of placebo. Furthermore, at week 16, tadalafil improved most HR-QOL ou …
Both the time to the first occurrence of clinical worsening and the incidence of clinical worsening were significantly reduced in recipients …
Tadalafil for the treatment of pulmonary arterial hypertension.
Rosenzweig EB. Rosenzweig EB. Expert Opin Pharmacother. 2010 Jan;11(1):127-32. doi: 10.1517/14656560903413542. Expert Opin Pharmacother. 2010. PMID: 20001434 Review.
OBJECTIVE: With several new agents emerging for the treatment of PAH, this article reviews tadalafil, the compound and its properties, clinical evidence supporting its use, and the role of tadalafil in the current treatment approach for patients with PAH. METHODS: A …
OBJECTIVE: With several new agents emerging for the treatment of PAH, this article reviews tadalafil, the compound and its properties …
3,181 results